Best 21 Panel Drug Test in America with Psilocybin, KRA, Xylazine, K2, TRA, KET, ETG & ADLTX, As low as $2.89

Analytes & Cut-off Levels:

Adulteration Checks (3-in-1)

Our 21 Panel Drug Test Cup comes equipped with three critical adulteration checks to ensure sample authenticity and prevent tampering:

• Specific Gravity: Detects overly diluted urine, ensuring the sample hasn’t been intentionally altered.

• pH Level: Identifies unnatural chemical imbalances in the urine, helping to spot tampered samples.
• Creatinine Level: Verifies the specimen is authentic human urine, ruling out substitutes or artificial samples.

Intended Use & Benefits
The 21 Panel Drug Test Cup offers enhanced screening compared to standard 10- or 12-panel tests. It enables detection of both traditional drugs of abuse and emerging substances of misuse, including substances like Fentanyl, Kratom, and Xylazine.

The built-in adulteration checks further support the integrity of the testing process by flagging any tampered or invalid samples, providing you with reliable, accurate results for critical decision-making.

Ideal Applications

This test cup is suitable for a wide range of professional settings, including:

• Pre-Employment, Random, and Post-Incident Workplace Drug Testing Programs

• Employee Health & Safety Monitoring

• Rehabilitation & Treatment Center Compliance Testing

• Probation, Parole, Juvenile Justice, and Correctional Facility Screening

• Clinical Toxicology & Medical Monitoring Protocols

Substances Detected in the 21-Panel Drug Test Cup

This 21 panel drug test cup is designed to screen a broad range of commonly misused and emerging substances. Each compound is listed with its cut-off level and the reason for its inclusion.

Amphetamine (AMP) – 1000 ng/mL
Detects amphetamine-type stimulants, often associated with increased alertness and focus but high potential for abuse. Regular screening helps maintain safe and compliant environments.

Opiates (OPI) – 300 ng/mL
Identifies traditional opiates such as morphine and codeine, which may be misused for their pain-relieving and euphoric properties. Monitoring reduces safety risks and misuse.

Methamphetamine (MET) – 1000 ng/mL
Detects potent stimulants with high addiction risk. Early detection supports intervention and reduces safety incidents.

Benzodiazepines (BZO) – 300 ng/mL
Screens for sedative medications used to treat anxiety or insomnia, which may impair coordination and judgment if misused.

Cocaine (COC) – 300 ng/mL
Identifies cocaine and its metabolites — a stimulant linked to short bursts of energy followed by fatigue and impaired focus. Testing helps ensure a drug-free workplace.

Methadone (MTD) – 300 ng/mL
Used in opioid maintenance therapy, methadone monitoring helps confirm appropriate medical use and prevent diversion.

Oxycodone (OXY) – 100 ng/mL
Detects a commonly prescribed opioid that carries a high risk of dependency. Screening supports medication control programs.

Buprenorphine (BUP) – 10 ng/mL
Included to ensure compliance in treatment settings and to detect potential misuse of this partial opioid agonist.

MDMA (Ecstasy) – 500 ng/mL
Detects MDMA, a psychoactive stimulant and hallucinogen, helping prevent incidents related to impaired perception or risky behavior.

Barbiturates (BAR) – 300 ng/mL
Identifies older sedatives that depress the nervous system and may lead to dependency or overdose.

Phencyclidine (PCP) – 25 ng/mL
Screens for dissociative drugs known to cause hallucinations and unpredictable behavior.

THC (Marijuana) – 50 ng/mL
Detects the main psychoactive compound in cannabis. Even in regions with legal use, testing remains vital for safety-sensitive roles.

Tramadol (TRA) – 100 ng/mL
Identifies an opioid-like pain reliever that can be habit-forming and impair cognitive performance when misused.

Synthetic Cannabinoids (K2/Spice) – 50 ng/mL
Detects designer cannabinoids significantly stronger than natural THC. Screening helps reduce risks of acute intoxication.

Ketamine (KET) – 1000 ng/mL
Monitors for recreational misuse of ketamine, an anesthetic associated with dissociative and hallucinogenic effects.

Fentanyl (FEN) – 20 ng/mL
Extremely potent synthetic opioid often involved in overdose cases. Detecting fentanyl can be lifesaving in prevention and monitoring programs.

Ethyl Glucuronide (ETG) – 300 ng/mL
Measures a direct alcohol metabolite that remains detectable long after consumption, ensuring compliance with sobriety and workplace policies.

Kratom (KRA) – 500 ng/mL
Screens for kratom, a plant-derived substance with stimulant and sedative properties. Detection helps address newer trends in substance use.

Xylazine (XYL) – 1000 ng/mL
A veterinary tranquilizer increasingly found in illicit drug mixtures. Testing helps identify dangerous adulteration or co-use.

Psilocybin/Psilocin (PSY) – 500 ng/mL
Detects hallucinogens found in “magic mushrooms.” Inclusion ensures broad coverage for both traditional and emerging substances.

Adulteration Tests (3-in-1)
Includes checks for Specific Gravity, pH, and Creatinine levels — verifying that each sample is authentic and untampered, ensuring reliable and defensible results.

Order Your 21-Panel Drug Test Cup Today!

Take a proactive approach to drug testing with our 21 Panel Drug Test Cup. Offering expanded detection for both traditional and emerging substances, this test cup ensures comprehensive screening that covers:

• Opioids, stimulants, hallucinogens, and more

• Newly prevalent substances like Fentanyl, Kratom, and Xylazine

The adulteration checks included in each cup guarantee sample authenticity, providing you with reliable results and reinforcing the credibility of your testing program.

Why Upgrade to the 21-Panel Drug Test Cup?

• Broader Detection Range: Perfect for keeping up with evolving drug misuse trends.

• Quick & Accurate Results: Rapid screening with clear results in just 5 minutes.

• Tamper-Proof: Built-in adulteration checks ensure the integrity of every sample.

Don’t wait to elevate your testing program’s accuracy and trustworthiness. Upgrade to the 21-Panel Drug Test Cup today and provide your organization with the most comprehensive rapid screening solution available.

For bulk orders or expert assistance, contact our team at (561) 897-9238 or email us at [email protected]